PROCEL 251 MG

ProCel® 251 MG is suitable for a broad range of biopharmaceutical productions such as therapeutic proteins, hormones, insulin, vaccines and antibiotics produced by recombinant and non-recombinant microorganisms. ProCel® 251 MG provides industrial performance and facilitates downstream processing thanks to its high solubility. ProCel® 251 MG is a primary yeast extract obtained by the autolysis of a selected strain of yeast, especially grown on a molasses-based media.